Blood-based Genomic Screening

BioNexus genome screening company


BioNexus Gene Lab Corporation (BGLC) applies non-invasive blood- based dynamic genome screening analysing changes in ribonucleic acid (RNA) predicting predisposed of certain diseases even before they show any symptoms. This blood test provides very early detection of a person’s susceptibility to certain diseases enabling the person to take appropriate measures to stay healthy.

BioNexus Covid-19 Testing


per person



per person for a minimum of  20 pax  on site within Klang Valley



 Make an appointment now at

03-7494  0760 /   012-383 2118 / 012-212 6512 

 or email to 


Meet Professor Dato' Dr. Liew Choong-Chin

Professor of Medicine and Founding Director of the Cardiovascular Genome Unit at Brigham and Women's Hospital, Harvard Medical School, and Professor Emeritus at the University of Toronto.


World renowned authority in the field of cardiovascular disease-specific genome research, one of the pioneers in the field of molecular medicine. He is the co-founder and chief scientist of Bionexus Gene Lab Corporation, and is a pioneer in the advancement of gene theory research into clinical application.

Screen Shot 2019-03-14 at 2.41.12 PM.png
BioNexus Genomic Screening


In the 1990s Professor Dato' Dr. Liew Choong-Chin, proposed a novel approach to identifying genomics signatures of diseases using blood. This unique blood signature approach derives from the observation that circulating blood reflects the changing states of the body in health and illness. This original concept won the Frost and Sullivan Innovation Award for North American Technology in the year 2006.


While DNA is relatively static, it is the carrier of human genetic information that passes down from generation to generation. Historically, the study of DNA is to detect ancestry and inherited characteristics, including certain inherited diseases like Huntington Disease, Cystic Fibrosis and Down Syndrome, among others. It is generally believed that there is a genetic (DNA) pre-disposition to certain cancers, like breast cancer, colon cancer and gastric cancer. 


Conversely, RNA is dynamic and changing affected by an individual’s lifestyle, diet, drug use, exercise and environment. The distinctions between the characteristic of RNA and DNA are illustrated in the link for more information

genome screening services


The BGS test is a new, non-invasive blood test that uses circulating RNA in the blood to assess an individual’s current risk for a panel of 14 diseases, BGS uses only gold standard and FDA approval reagents and instrument to ensure the quality of results.